METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX)
Anterior Shoulder Dislocation
About this trial
This is an interventional treatment trial for Anterior Shoulder Dislocation
Eligibility Criteria
Inclusion Criteria: Pregnant and/or breastfeeding women and women of childbearing age who do not have effective contraception (hormonal, mechanical or surgical). Patients with difficulties in understanding or using the devices studied. Patients with a contraindication to the use of one of the studied devices. Patients with a history of relevant shoulder surgery Presence of other associated trauma, Previous inclusion in the same study Exclusion Criteria: Withdrawal of voluntary informed consent from the patient Violation of protocol Presence of a fracture associated with the dislocation (excluding Malgaigne's notches) Posterior, inferior or erecta dislocation Presence of initial vascular and nerve complications Any indication for surgical management
Sites / Locations
- Nice University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Standard of care
Medical device : VR headset
Medication : Methoxyflurane analgesia
An anticipated analgesia protocol composed of PARACETAMOL 1g +/- OXYNORM 5 mg or 10 mg according to patients weight and pain intensity as evaluated by a simple numeric rating scale is administred prior to the reduction procedure. Inhaled equimolar mixture of oxygen and notrous oxyde (MEOPA) at a 15L/min flux is administered concomitantly to the reduction procedure.
Use of a " virtual reality " (VR) headset of " Pico G2 " type with " HypnoVR " software and audio headset " Taotronics BH22 " during all the reduction care
Self administered inhalated methoxyflurane (maximal inhaled dose : 3 mL)